Gilde Healthcare participates in €51M series A financing of Noema Pharma
– €51 million to advance a pipeline of four clinical-stage product candidates in-licensed from Roche to treat orphan neurological disorders Highly experienced team leverages latest scientific discoveries in neuroscience Gilde Healthcare joins an international investor syndicate…